157 related articles for article (PubMed ID: 34900539)
1. Self-assembled ternary hybrid nanodrugs for overcoming tumor resistance and metastasis.
Cheng X; Li D; Xu J; Wei B; Fang Q; Yang L; Xue Y; Wang X; Tang R
Acta Pharm Sin B; 2021 Nov; 11(11):3595-3607. PubMed ID: 34900539
[TBL] [Abstract][Full Text] [Related]
2. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.
Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y
Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335
[TBL] [Abstract][Full Text] [Related]
3. Overcoming the diverse mechanisms of multidrug resistance in lung cancer cells by photodynamic therapy using pTHPP-loaded PLGA-lipid hybrid nanoparticles.
Pramual S; Lirdprapamongkol K; Jouan-Hureaux V; Barberi-Heyob M; Frochot C; Svasti J; Niamsiri N
Eur J Pharm Biopharm; 2020 Apr; 149():218-228. PubMed ID: 32112893
[TBL] [Abstract][Full Text] [Related]
4. Computer-assisted engineering of programmed drug releasing multilayer nanomedicine via indomethacin-mediated ternary complex for therapy against a multidrug resistant tumor.
Che L; Liu Z; Wang D; Xu C; Zhang C; Meng J; Zheng J; Yuan H; Zhao G; Zhou X
Acta Biomater; 2019 Oct; 97():461-473. PubMed ID: 31344512
[TBL] [Abstract][Full Text] [Related]
5. Co-Delivery of Trichosanthin and Albendazole by Nano-Self-Assembly for Overcoming Tumor Multidrug-Resistance and Metastasis.
Tang Y; Liang J; Wu A; Chen Y; Zhao P; Lin T; Zhang M; Xu Q; Wang J; Huang Y
ACS Appl Mater Interfaces; 2017 Aug; 9(32):26648-26664. PubMed ID: 28741923
[TBL] [Abstract][Full Text] [Related]
6. A new insight into the reversal of multidrug resistance in cancer by nanodrugs.
Jiang H; Guo D; Chen D; Wu Y; Jin X; Zhu X
Biomater Sci; 2019 Aug; 7(8):3489-3496. PubMed ID: 31282916
[TBL] [Abstract][Full Text] [Related]
7. Indomethacin-grafted and pH-sensitive dextran micelles for overcoming inflammation-mediated multidrug resistance in breast cancer.
Zeng X; Cheng X; Zheng Y; Yan G; Wang X; Wang J; Tang R
Carbohydr Polym; 2020 Jun; 237():116139. PubMed ID: 32241443
[TBL] [Abstract][Full Text] [Related]
8. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
9. pH/redox sequentially responsive nanoparticles with size shrinkage properties achieve deep tumor penetration and reversal of multidrug resistance.
Feng W; Zong M; Wan L; Yu X; Yu W
Biomater Sci; 2020 Sep; 8(17):4767-4778. PubMed ID: 32724941
[TBL] [Abstract][Full Text] [Related]
10. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
11. Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA.
Yuan Y; Liu J; Yu X; Liu X; Cheng Y; Zhou C; Li M; Shi L; Deng Y; Liu H; Wang G; Wang L; Wang Z
Acta Biomater; 2021 Nov; 135():556-566. PubMed ID: 34496281
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of multiple drug resistance inhibitors by polymer/inorganic hybrid nanoparticles to effectively reverse cancer drug resistance.
Wu C; Gong MQ; Liu BY; Zhuo RX; Cheng SX
Colloids Surf B Biointerfaces; 2017 Jan; 149():250-259. PubMed ID: 27768915
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin and adjudin co-loaded pH-sensitive nanoparticles for the treatment of drug-resistant cancer.
Wang Q; Zou C; Wang L; Gao X; Wu J; Tan S; Wu G
Acta Biomater; 2019 Aug; 94():469-481. PubMed ID: 31141733
[TBL] [Abstract][Full Text] [Related]
14. The use of liposomal anticancer agents to determine the roles of drug pharmacodistribution and P-glycoprotein (PGP) blockade in overcoming multidrug resistance (MDR).
Krishna R; Mayer LD
Anticancer Res; 1999; 19(4B):2885-91. PubMed ID: 10652569
[TBL] [Abstract][Full Text] [Related]
15. pH and redox dual-responsive nanoparticles based on disulfide-containing poly(β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer.
Zhang S; Guo N; Wan G; Zhang T; Li C; Wang Y; Wang Y; Liu Y
J Nanobiotechnology; 2019 Oct; 17(1):109. PubMed ID: 31623608
[TBL] [Abstract][Full Text] [Related]
16. NO-releasing polypeptide nanocomposites reverse cancer multidrug resistance via triple therapies.
Ding Y; Ma Y; Du C; Wang C; Chen T; Wang Y; Wang J; Yao Y; Dong CM
Acta Biomater; 2021 Mar; 123():335-345. PubMed ID: 33476826
[TBL] [Abstract][Full Text] [Related]
17. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
18. Overcoming Multidrug Resistance by Codelivery of MDR1-Targeting siRNA and Doxorubicin Using EphA10-Mediated pH-Sensitive Lipoplexes: In Vitro and In Vivo Evaluation.
Zhang J; Du Z; Pan S; Shi M; Li J; Yang C; Hu H; Qiao M; Chen D; Zhao X
ACS Appl Mater Interfaces; 2018 Jun; 10(25):21590-21600. PubMed ID: 29798663
[TBL] [Abstract][Full Text] [Related]
19. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel-Loaded Chitosan-Cholesterol Conjugate-Based Self-Assembled Nanoparticles for Overcoming Multidrug Resistance in Cancer Cells.
Mu CF; Cui F; Yin YM; Cho HJ; Kim DD
Pharmaceutics; 2020 Aug; 12(9):. PubMed ID: 32825000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]